HSP90AA1 and cardiovascular disorder: HSP90AA1 (also known as HSP90A), a therapeutic target for cardiovascular disease and cardiac ageing, has been reported to mediate angiogenesis by direct binding to semi-synthetic triterpenoids [28,29], and it was found to be strongly related to the severity degree of COVID-19 disease [30].